Piper Sandler Maintains Overweight on Guardant Health, Lowers Price Target to $190
Benzinga Newsdesk 6 hours ago
Analyst RatingsNewsPrice Target
Piper Sandler analyst David Westenberg maintains Guardant Health (NASDAQ:GH) with a Overweight and lowers the price target from $193 to $190.
Piper Sandler analyst David Westenberg maintains Guardant Health (NASDAQ:GH) with a Overweight and lowers the price target from $193 to $190.